Magic Mushrooms Outperform Dangerous SSRI Drugs in New Study on Depression


By Jason Erickson

As the dangers of SSRIs offered by Big Pharma continue to be documented, science is finally confirming what many natural health advocates have been arguing for years, namely that many of the illegal substances that have been propagandized to be shunned by the public are far safer and more effective alternatives.

For those who still might not have come across the amazing website SSRI Stories, I’ll offer you a snippet from their intro to hopefully pique further investigation:

SSRI Stories is a collection of over 6,000 stories that have appeared in the media (newspapers, TV, scientific journals) in which prescription drugs were mentioned and in which the drugs may be linked to a variety of adverse outcomes including violence.

Widget not in any sidebars


SSRI Stories focuses primarily on problems caused by selective serotonin reuptake inhibitors (SSRIs), of which Prozac (fluoxetine) was the first.  For more see About SSRIs.  Other medications prescribed as antidepressants that fit the “nightmares” theme of the collected stories are sometimes included.


More than 6,000 stories! A nightmare indeed. And, yet, parents continue to accept the increased push to give SSRIs to children who exhibit behaviors that are, well, childish. Instead, society has been conditioned to educate children (and adults) about the terrifying dangers of natural substances such as cannabis, LSD, and “magic” mushrooms (psilocybin), of which psilocybin is still considered to be a Schedule 1 drug by international standards: “defined as drugs with a high potential for abuse or drugs that have no recognized medical uses.”

The most recent outcome of human trials conducted in the U.K. further illustrates how foolish and factually incorrect this worldview has become.

The prominent publication Lancet Psychology has published new results from a study of 12 severely depressed individuals who on average had symptoms for nearly 2 decades. None had responded to conventional treatments, including SSRIs. The outcome after receiving just one dose was astonishing:

One week after receiving an oral dose of psilocybin, all patients experienced a marked improvement in their symptoms. Three months on, five patients were in complete remission.

The equivalent remission rate for SSRIs is around 20%.


Modern society is unfortunately rife with depression to epidemic levels that are still rising. The fact that there are an increasing number of pharmaceutical-free solutions to depression is something that needs to be shared widely to friends and family who may be struggling.  Please share this article as the latest example of the type of research we should support more widely.

(Editor’s Note: We also recommend that you visit the fantastic work on natural mental health that is being done by Dr. Kelly Brogan – a former traditional medical doctor turned holistic psychiatrist. Dr. Brogan offers an uplifting vision of a world free from pharmaceuticals which could dramatically turn the tide of disability brought about by depression. Please see her book A Mind of Your Own for more information.)

Image Credit

This article (Magic Mushrooms Outperform Dangerous SSRI Drugs in New Study) is free and open source. We welcome you to republish online with attribution to the author, original story and Natural Blaze under a share-alike Creative Commons license. Please provide a link back if you write a version of this story after reading ours.

Become a Natural Blaze Patron and Support Health Freedom

Become a Patron!

Get Natural Health News Delivered

Enter Email Below To Stay Informed!

Widget not in any sidebars

10 Best Books To Survive Food Shortages & Famines

Your survival library won’t be complete without these books!

Plus get top natural health news delivered daily. Stay informed about health and food freedom, holistic remedies, and preparedness.

Claim your FREE download TODAY!

Enter your email address below to get instant access!

Enter Email Below To Stay Informed!

Thank you for sharing. Follow us for the latest updates.
Send this to a friend